Insider Buy/Sell Ratio for August 2026
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Consumer Cyclical
Buys62
Sells658
Buy $$25.45M
Sell $$3.71B
Ratio1:145.85
% Change vs. Prior
Ratio +108.1%Value +169.4%
Technology
Buys105
Sells2754
Buy $$50.84M
Sell $$3.35B
Ratio1:65.89
% Change vs. Prior
Ratio -70.2%Value +43.7%
Healthcare
Buys144
Sells1305
Buy $$101.82M
Sell $$1.79B
Ratio1:17.56
% Change vs. Prior
Ratio +86.0%Value +13.2%
Financial Services
Buys272
Sells1010
Buy $$31.08M
Sell $$1.69B
Ratio1:54.32
% Change vs. Prior
Ratio -96.5%Value +39.7%
Industrials
Buys143
Sells680
Buy $$370.96M
Sell $$973.11M
Ratio1:2.62
% Change vs. Prior
Ratio +1375.9%Value +70.7%
Energy
Buys65
Sells258
Buy $$48.47M
Sell $$1.19B
Ratio1:24.45
% Change vs. Prior
Ratio +187.8%Value +674.9%
Consumer Defensive
Buys42
Sells158
Buy $$12.07M
Sell $$1.12B
Ratio1:92.44
% Change vs. Prior
Ratio -95.6%Value +493.1%
Communication Services
Buys51
Sells309
Buy $$35.11M
Sell $$436.61M
Ratio1:12.44
% Change vs. Prior
Ratio +12431.4%Value +200.6%
Basic Materials
Buys54
Sells87
Buy $$6.33M
Sell $$98.10M
Ratio1:15.50
% Change vs. Prior
Ratio -93.2%Value +603.0%
Real Estate
Buys90
Sells82
Buy $$22.20M
Sell $$62.09M
Ratio1:2.80
% Change vs. Prior
Ratio +2719.2%Value +252.5%
Utilities
Buys21
Sells48
Buy $$6.57M
Sell $$9.25M
Ratio1:1.41
% Change vs. Prior
Ratio +261.5%Value -56.6%
By Industry
Apparel - Footwear & Accessories
Buys0
Sells29
Buy $$0.00
Sell $$1.11B
RatioAll Sells
Specialty Retail
Buys11
Sells272
Buy $$2.58M
Sell $$1.07B
Ratio1:416.80
% Change vs. Prior
Ratio -44.4%Value +412.9%
Software - Infrastructure
Buys17
Sells913
Buy $$2.50M
Sell $$1.04B
Ratio1:417.37
% Change vs. Prior
Ratio +156.3%Value +109.6%
Beverages - Non-Alcoholic
Buys2
Sells5
Buy $$2.00M
Sell $$1.00B
Ratio1:500.50
Banks - Regional
Buys114
Sells443
Buy $$6.52M
Sell $$720.42M
Ratio1:110.51
Biotechnology
Buys70
Sells656
Buy $$82.75M
Sell $$619.07M
Ratio1:7.48
% Change vs. Prior
Ratio +306.4%Value -46.6%
Leisure
Buys3
Sells39
Buy $$746.99K
Sell $$671.06M
Ratio1:898.35
Computer Hardware
Buys0
Sells356
Buy $$0.00
Sell $$626.10M
RatioAll Sells
% Change vs. Prior
Ratio NaN%Value +22.6%
Asset Management
Buys60
Sells53
Buy $$14.05M
Sell $$585.26M
Ratio1:41.66
% Change vs. Prior
Ratio -96.7%Value +237.6%
Information Technology Services
Buys3
Sells73
Buy $$2.19M
Sell $$549.26M
Ratio1:250.69
Software - Application
Buys38
Sells777
Buy $$34.23M
Sell $$483.44M
Ratio1:14.12
% Change vs. Prior
Ratio -53.6%Value -24.4%
Oil & Gas Equipment & Services
Buys5
Sells57
Buy $$4.52M
Sell $$510.40M
Ratio1:112.96
Semiconductors
Buys38
Sells329
Buy $$10.73M
Sell $$345.43M
Ratio1:32.19
% Change vs. Prior
Ratio +1121.0%Value +4.6%
Waste Management
Buys31
Sells7
Buy $$346.52M
Sell $$3.26M
Ratio106.28:1
Medical - Diagnostics & Research
Buys6
Sells272
Buy $$2.08M
Sell $$341.85M
Ratio1:164.23
Transactions (8717)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
NETFLIX INC (NFLX)
Peters Gregory K — Director
Shares
27,312
Price
$73.54
Total Value
$2.01M
Shares Held After
120,931
% of Holdings
18.4%
Velocity Financial, Inc. (VEL)
Szczepaniak Mark R — Chief Financial Officer
Shares
400
Price
$18.00
Total Value
$7.20K
Shares Held After
66,400
% of Holdings
0.6%
Burke&Herbert Financial Services Corp. (BHRB)
McLaughlin Shawn Patrick — Director
Shares
1,000
Price
$73.25
Total Value
$73.25K
Shares Held After
71,000
% of Holdings
1.4%
Rhinebeck Bancorp, Inc. (RBKB)
Vitale Michael — EVP, Head of Comm Banking
Shares
4,834
Price
$12.35
Total Value
$59.70K
Shares Held After
22,414
% of Holdings
21.6%
WILSON BANK HOLDING CO (WBHC)
CLEMONS JAMES RANDALL — Director
Shares
2,982
Price
$83.45
Total Value
$248.85K
Shares Held After
116,090
% of Holdings
2.6%
FARMERS NATIONAL BANC CORP /OH/ (FMNB)
Wenick Mark J — SEVP/Chief Wealth Mgt Officer
Shares
5,000
Price
$15.97
Total Value
$79.85K
Shares Held After
32,020
% of Holdings
13.5%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
6,975
Price
$44.44
Total Value
$309.97K
Shares Held After
0
% of Holdings
100.0%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
25
Price
$46.56
Total Value
$1.16K
Shares Held After
6,975
% of Holdings
0.4%
Thornburg Income Builder Opportunities Trust (TBLD)
Kritzmire Anne W. — TRUSTEE
Shares
3,440
Price
$22.20
Total Value
$76.37K
Shares Held After
4,840
% of Holdings
71.1%
Infleqtion, Inc. (INFQ)
MAVERICK CAPITAL LTD — Director
Shares
1,324
Price
$10.88
Total Value
$14.41K
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
753
Price
$21.97
Total Value
$16.54K
Shares Held After
75,542
% of Holdings
1.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$22.11
Total Value
$2.21K
Shares Held After
76,295
% of Holdings
0.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
480
Price
$21.55
Total Value
$10.34K
Shares Held After
76,395
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.10
Total Value
$4.42K
Shares Held After
76,875
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
3,402
Price
$22.02
Total Value
$74.91K
Shares Held After
77,075
% of Holdings
4.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,556
Price
$22.06
Total Value
$34.33K
Shares Held After
80,477
% of Holdings
1.9%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
82,033
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,332
Price
$22.03
Total Value
$29.34K
Shares Held After
82,233
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
447
Price
$21.87
Total Value
$9.78K
Shares Held After
83,565
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
988
Price
$22.03
Total Value
$21.77K
Shares Held After
84,012
% of Holdings
1.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
85,000
Price
$21.00
Total Value
$1.78M
Shares Held After
85,000
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Showing 251–300 of 8717 transactions (page 6 of 175)